Showing results (1001-1010 of 1,028) with videos related to

Sort By:
Pageof 103
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Nature Communications|February 20, 2024
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohortAnwaar Saeed, Robin Park, Harsh Pathak, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesiclesTamer Kahraman, Gozde Gucluler Akpinar, Muzaffer Yildirim, et al.
Annals of Saudi Medicine|December 7, 2021
Characteristics and outcomes of 974 COVID-19 patients in intensive care units in TurkeyHülya Sungurtekin, Cansu Ozgen, Ulku Arslan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Clinicopathological features in bilateral breast cancerMeltem Baykara, Selcuk Cemil Ozturk, Suleyman Buyukberber, et al.
The Journal of Clinical Investigation|July 1, 2021
Passive transfer of fibromyalgia symptoms from patients to miceAndreas Goebel, Emerson Krock, Clive Gentry, et al.
Journal of Infection in Developing Countries|April 11, 2022
Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patientsImran Saglik, Beyza Ener, Halis Akalin, et al.
Breast Care (Basel, Switzerland)|October 11, 2016
Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)Muhammet A Kaplan, Ulku Y Arslan, Abdurrahman Işıkdogan, et al.
European Journal of Human Genetics : EJHG|March 16, 2006
Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraineKaate R J Vanmolkot, Esther E Kors, Ulku Turk, et al.
Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.
Pageof 103